FERNANDO ANTONIO
RODRÍGUEZ DE FONSECA
Catedrático de universidad
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (55)
2023
-
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
International journal of molecular sciences, Vol. 24, Núm. 11
-
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 21
-
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 113
-
Attenuation of oleoylethanolamide-induced reduction of alcohol consumption in adult rats exposed intermittently to alcohol during adolescence
Neuroscience Letters, Vol. 781
-
Maternal hypercaloric diet affects factors involved in lipid metabolism and the endogenous cannabinoid systems in the hypothalamus of adult offspring: sex-specific response of astrocytes to palmitic acid and anandamide
Nutritional Neuroscience, Vol. 25, Núm. 5, pp. 931-944
-
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Biomedicines, Vol. 10, Núm. 5
2021
-
A combination of circulating chemokines as biomarkers of obesity-induced insulin resistance at puberty
Pediatric Obesity, Vol. 16, Núm. 2
2020
-
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β
Neuropharmacology, Vol. 162
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1
2019
2016
-
Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators
BioFactors, Vol. 42, Núm. 6, pp. 600-611
-
Chronic IL-6 administration desensitizes IL-6 response in liver, causes hyperleptinemia and aggravates steatosis in diet-induced-obese mice
PLoS ONE, Vol. 11, Núm. 6
-
Effects of adolescent intermittent alcohol exposure on the expression of endocannabinoid signaling-related proteins in the spleen of young adult rats
PLoS ONE, Vol. 11, Núm. 9
-
Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice
British Journal of Pharmacology, Vol. 173, Núm. 6, pp. 1070-1084
2015
-
Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
DMM Disease Models and Mechanisms, Vol. 8, Núm. 7, pp. 721-731
-
Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation
Journal of Medicinal Chemistry, Vol. 58, Núm. 16, pp. 6639-6652